[The effect of diet with the sour-milk product enriched with amaranth on parameters of antioxigen protection at patients with a cardiovascular pathology].

Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis (2007) 1.04

[The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. Vopr Pitan (2012) 0.81

[Comparative study of effects of diet therapy including eiconol or linseed oil on several parameters of lipid metabolism in patients with type 2 diabetes mellitus]. Vopr Pitan (2001) 0.80

[ELISA and PCR test systems used to detect Crimean-Congo hemorrhagic fever virus]. Vopr Virusol (2007) 0.80

[The clinical and experimental research of metabolic effects of shark liver oil]. Vopr Pitan (2007) 0.78

[Clinical use of flavonoid enriched biologically active food supplements in patients with chronic atrophic gastritis in combination with chronic cholecystitis or bile ducts dyskinesia]. Vopr Pitan (2003) 0.78

[Influence of dietary therapy containing sunflower oil fortified with phospholipids on the lipid metabolism in patients with hypertension and obesity]. Vopr Pitan (2007) 0.77

[Formation of focus of West Nile fever on the territory of Saratov Region]. Zh Mikrobiol Epidemiol Immunobiol (2014) 0.77

[A circulation study of California serogroup and Batai viruses (fam. Bunyaviridae, genus Bunyavirus) on the territory of Saratov Province]. Med Parazitol (Mosk) (1997) 0.76

[Effects of a diet including linseed oil on clinical and metabolic parameters in patients with type 2 diabetes mellitus]. Vopr Pitan (2000) 0.76

[Effects of anti-atherosclerosis diet containing omega 3 fatty acids on the lipid spectrum of blood and cell membranes in patients with ischemic heart disease and essential hypertension]. Vopr Pitan (1991) 0.76

[Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance]. Vopr Pitan (2000) 0.76

[Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.76

[The effect of an antiatherosclerotic diet including omega-3 polyunsaturated fatty acids of marine and plant origins on the indices of cellular and humoral immunity in patients with ischemic heart disease and a disordered carbohydrate tolerance]. Vopr Pitan (2000) 0.76

[Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet]. Vopr Pitan (1997) 0.76

[Effects of diet therapy including eiconol on clinical and metabolic parameters in patients with type 2 diabetes mellitus]. Vopr Pitan (2000) 0.76

[Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia]. Vopr Pitan (1997) 0.76

[Influence of tableted green tea on index the antioxidant status patients with disease digestion organs]. Vopr Pitan (2008) 0.76

[Degradation of endo- and exogenous albumin in normal and starved rats]. Vopr Med Khim (1993) 0.76

[Immune and metabolic effect of polyunsaturated fatty acids omega 3 in anti-atherosclerotic diet in the treatment of patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan (1994) 0.76

[Effect of selenium enriched diet on lipid peroxidation in patients with diabetes mellitus type 2]. Vopr Pitan (2003) 0.76

The Health and Functioning ICF-60: development and psychometric properties. Clin Psychol Psychother (2014) 0.75

[The study of the clinical potency of antiatherogenic diet containing flavonoids in cardiovascular patients]. Vopr Pitan (2003) 0.75

[Effect of antiatherosclerotic diet, containing polyunsaturated fatty acids of the omega-3 family from flax oil, on fatty acid composition of cell membranes of patients with ischemic heart disease. Hypertensive disease and hyperlipoproteinemia]. Vopr Pitan (1997) 0.75

[Use of phytoestrogens in medicine]. Vopr Pitan (2003) 0.75

[Peculiarity mineralization of osteous tissue of patients wits cardiovascular and gastroenteric pathologic and provision with vitamins and calcium]. Vopr Pitan (2008) 0.75

[Application of nutritional formulare in the dietotherapy in patients with cardiovascular diseases]. Vopr Pitan (2005) 0.75

[Dietary fibers in diet therapy]. Vopr Pitan (1998) 0.75

[Evaluation of the effects of fish and vegetable omega-3 PUFA complex on the erythrocyte fatty acid composition in patients with ischemic heart disease and impaired glucose tolerance]. Vopr Pitan (1999) 0.75

[Marine fish oil in the prevention and treatment of cardiovascular diseases]. Vestn Ross Akad Med Nauk (1996) 0.75

[The study of polymorphism rs9939609 FTO gene in patients with overweight and obesity]. Vopr Pitan (2011) 0.75

[Antioxidant level and lipid metabolism in patients with cardiovascular disease]. Vopr Pitan (2007) 0.75

[Effect of diet therapy on metabolism of prostaglandins in patients with hypertension and obesity]. Vopr Pitan (1998) 0.75

[Homocysteine as a coronary risk factor]. Vopr Pitan (2003) 0.75

[Analysis of regulatory basis for organization of clinical nutrition in medical institutions of the Russian Federation]. Vopr Pitan (2013) 0.75

[Efficiency of diet therapy containing carbohydrate-protein product enriched with vitamins and minerals in patients with cardiovascular diseases, obesity, and osteopenia]. Vopr Pitan (2008) 0.75

[The study of FTO rs9939609-gene polymorphism in the Sverdlovsk Region]. Vopr Pitan (2012) 0.75

[Effects of biologically active supplements on the antioxidant and vitamin status of patients with hypertension and ischemic heart disease]. Vopr Pitan (2001) 0.75

[Effect of thiamine deficiency in hydrochloric acid secretion in the stomach]. Vopr Pitan (1979) 0.75

[Fat and content of yakutan horse fat tissue]. Vopr Pitan (2005) 0.75

[Peculiarities of vitamin status in men and women with cardiovascular disease and obesity]. Vopr Pitan (2012) 0.75

[Comparative study on the effect of antiatherosclerotic diet enriched with polyunsaturated omega-3 fatty acids of plant and animal origin on the level of natural antibodies against catecholamines in patients with cardiovascular diseases]. Vopr Pitan (1998) 0.75

[The study of soy isoflavone metabolism in patients with cardiovascular diseases]. Vopr Pitan (2002) 0.75

[Influence of chitosan on clinical-biochemical rates and protein metabolism of patients with cardiovascular diseases]. Vopr Pitan (2008) 0.75

[Clinical-metabolic evaluation of the effectiveness of the olive oil use in patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75

[The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia]. Vopr Pitan (2003) 0.75

[Effect of anti-atherosclerotic diet with polyunsaturated fatty acids omega-3 from linseed oil on dynamics of natural antibodies to bradykinin and angiotensin II in blood serum of patients with cardiovascular diseases]. Vopr Pitan (1998) 0.75

[The role of the Consultative and Diagnostic Centre "Healthy Nutrition" in the diagnosis and nutritional prevention of non-communicable diseases]. Vopr Pitan (2014) 0.75

[The study of the peculiarities of metabolism in individuals with rs9939609 polymorphism of FTO gene]. Vopr Pitan (2015) 0.75

[Dietary fiber influence on vitamins assimilation in patients suffering from cardiovascular diseases and adiposity]. Vopr Pitan (2010) 0.75

[Effects of antiatherosclerosis diet including soy protein on the dynamics of clinical, biochemical and immunologic indicators in patients with ischemic heart disease and hypertension]. Vopr Pitan (1999) 0.75

[Determination of natural antibodies to catecholamines in health and disease]. Ter Arkh (1998) 0.75

[Definite of nutritional status in patients with metabolic syndrome with the use of modern methods of nutrimetabolomica]. Vopr Pitan (2010) 0.75

[The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. Vopr Pitan (2006) 0.75

[Regional features of obesity-associated gene polymorphism (rs9939609 FTO gene and gene Trp64Arg ADRB3) in Russian population]. Vopr Pitan (2014) 0.75

[Clinical and metabolic effects of biological active food additives--phospholipids--in patients with cardiovascular diseases]. Vopr Pitan (1997) 0.75

[Genetic approaches to nutrition personalization]. Vopr Pitan (2012) 0.75

[Study of fatty acid composition of cell membranes during the use of soya oil in diet therapy of patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75

[Current views of nutritional therapy]. Klin Med (Mosk) (2009) 0.75

[Evaluating the effectiveness of dietary management of patients with varying degrees of obesity]. Vopr Pitan (2014) 0.75

[Study of the state of lipid peroxidation system: antioxidant protection during the use of soy oil in patients with ischemic heart disease and hypertension]. Vopr Pitan (2000) 0.75

[Energy metabolic in patients with ischemic heart disease before and after heart surgery]. Vopr Pitan (2007) 0.75

[Analysis by bioelectrical impedance of body composition of patients with cardiovascular diseases and obesity]. Vopr Pitan (2005) 0.75

[The use of natural phytosterins for correction of abnormalities of lipid metabolism]. Kardiologiia (2011) 0.75

[Dynamics of the natural antibody level as affected by the biologically active food supplement "Vitol" in patients with hypertensive disease and obesity]. Vopr Pitan (1999) 0.75

[Use of fish oil enriched with carotenoids isolated from sea cucumbers in the diet therapy of patients with hypertension and ischemic heart disease]. Vopr Pitan (2003) 0.75

[Correction of mineral metabolism impairment with an allowance for seasonal fluctuations in patients with ischemic heart disease and hypertensive disease with overweight]. Vopr Pitan (2001) 0.75

[Effect of an anti-atherogenic diet, including soy protein products with various levels of phytoestrogens, on indicators of humoral immunity in patients with hypertension and ischemic heart disease]. Vopr Pitan (2002) 0.75

[Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates]. Klin Med (Mosk) (2003) 0.75

[Features to improve health care in "dietology" profile in Voronezh Region]. Vopr Pitan (2013) 0.75

[Vitamin status and bone mineral density at patients with adiposity and the cardiovascular pathology]. Vopr Pitan (2008) 0.75

[Effect of tetracycline on rat liver mitochondrial oxidative phosphorylation in vivo and in vitro under a varying body allowance of protein]. Vopr Pitan (1978) 0.75

[Evaluation of dietary therapy efficiency, based on clinical and biochemical parameters in patients with cardiovascular disease and osteopenia]. Vopr Pitan (2007) 0.75

[Immunoenzyme technique for detection of natural antibodies to bradykinin in cardiovascular diseases]. Klin Lab Diagn (2001) 0.75

[Oxidative enzyme activity in the gastric mucosa in gastroduodenitis in children]. Pediatriia (1980) 0.75

[Effects of anti-atherosclerotic low-sodium diet on dynamics of natural antibodies to angiotensin II, bradykinin and vasopressin in blood of patients with hypertension and obesity]. Vopr Pitan (2001) 0.75

[Biologically active food supplements in comprehensive therapy of patients with ischemic heart disease and hypertension and the background of overweight]. Vopr Pitan (2000) 0.75

[Experience of phytosterols' application in dietetic cardiovascular diseases]. Vopr Pitan (2008) 0.75

[Study of metabolic and clinical effects of polyunsaturated fatty acids omega-3 from "Eicovit" in patients with ischemic heart disease and familial hyperlipoproteinemia]. Vopr Pitan (1998) 0.75

[The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. Vopr Pitan (2006) 0.75

[Using diet therapy based on complex assessment of nutritional status in patient with cardiovascular diseases and obesity]. Vopr Pitan (2007) 0.75

[Efficiecy of application assessment of grain bread in diettherapy of patients of elderly ages with cardiovascular diseases]. Vopr Pitan (2006) 0.75

[The use of nutritional antioxidants for the correction of metabolic disorders of cardiovascular patients]. Vopr Pitan (2004) 0.75

[The study of the association of polymorphism rs659366 gene UCP2 c obesity and type 2 diabetes among residents of the Moscow Region]. Vopr Pitan (2015) 0.75

[The assessment of clinical efficiency of the diet therapy in cardiosurgery patients]. Vopr Pitan (2007) 0.75

[The homeostatic changes of mineral and trace elements during of year at rheumatoid arthritis]. Vopr Pitan (2006) 0.75

[Effect of diet enriched with selenium on the psycho-emotional and adaptive capacity of patients with cardiovascular diseases and obesity]. Vopr Pitan (2012) 0.75

[The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases]. Vopr Pitan (2005) 0.75

[Multilevel study of actual nutrition in the complex analysis of nutritial status of patients with obesity]. Vopr Pitan (2009) 0.75

[The system of multilevel diagnostics and corrections of nutrition status disorders in the patients with cardiovascular diseases]. Vopr Pitan (2009) 0.75

[The nutrition analysis of the patients with cardio-vascular diseases]. Vopr Pitan (2005) 0.75

[Efficacy of the use of a sour milk product enriched with phytosterols in diet therapy of patients with cardiovascular diseases]. Kardiologiia (2008) 0.75

[Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods]. Vopr Pitan (2002) 0.75

[Clinical efficiency of using laminaria jam enriched with selenium]. Vopr Pitan (2009) 0.75

[Soybean proteins in correction of coronary risk factors in patients with cardiovascular diseases]. Vopr Pitan (2002) 0.75

[The study of the association of polymorphism rs5219 gene KCNJ11 with obesity and the risk of type 2 diabetes among residents of the Moscow Region]. Vopr Pitan (2015) 0.75

[The investigation of influent of antiatherosclerotic diets with inulin on clinical and metabolic parameters in patients with cardiovascular diseases]. Vopr Pitan (2006) 0.75

[Dietary correction of nutrition status in patients with metabolic syndrome]. Vopr Pitan (2009) 0.75

[Analysis of modern concepts concerning the role of processed soybean products in diet therapy of patients with cardiovascular diseases]. Vopr Pitan (2000) 0.75

[Morphologic, biochemical and functional properties of the mitochondria of the rabbit gastric mucosa]. Tsitologiia (1975) 0.75